Related Experiment Videos
Molecular stool screening for colorectal cancer
1Department of General Surgery, Manchester Royal Infirmary, Manchester, UK. Tonymak2000@hotmail.com
The British Journal of Surgery
|July 1, 2004
Summary
Molecular stool-based tests show high sensitivity and specificity for colorectal cancer screening. Further clinical trials are needed to confirm these promising results for widespread adoption.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Diagnostics
Background:
- Colorectal cancer (CRC) screening significantly reduces mortality.
- Advances in molecular genetics have led to promising molecular stool-based tests.
- This review examines the innovation and clinical significance of molecular stool testing for CRC.
Purpose of the Study:
- To review recent innovations in molecular stool-based colorectal cancer screening.
- To discuss the clinical significance of these advanced molecular diagnostic tools.
Main Methods:
- Systematic literature search using Medline database for key articles.
- Manual scanning of reference lists from identified publications to ensure comprehensive review.
Main Results:
- Current CRC screening includes endoscopic, radiological, and stool-based methods.
- Molecular stool testing demonstrates high sensitivity and specificity.
- Tumor markers are increasingly utilized in screening due to understanding of the adenoma-carcinoma sequence.
Conclusions:
- Recent molecular stool tests exhibit improved sensitivity and specificity compared to earlier iterations.
- Larger clinical trials are necessary to validate these findings.
- Ongoing research aims to enhance laboratory methods for improved sensitivity and large-scale applicability.